期刊: EUROPEAN JOURNAL OF CANCER, 2023; 187 ()
Purpose: Unresectable, locally advanced sinonasal epithelial tumours are rare diseases with poor prognosis. Multimodal approach is widely used, althou......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 191 ()
Purpose: The safety and objective clinical responses were observed in the phase I study using adjuvant autologous tumour-infiltrating lymphocytes (TIL......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 194 ()
Background: The incidence of early-onset pancreatic cancer (EOPC) has risen dramatically in recent years. We aimed to characterise the clinical and ge......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 194 ()
Aim: Myoepithelial carcinoma occurs mainly in salivary glands but rarely can also occur in soft tissues or bone. In this paper, we evaluated the role ......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 182 ()
Introduction: Bone metastases (BM) in renal cell carcinoma (RCC) are associated with a poor prognosis based on retrospective studies evaluating antian......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 186 ()
Objective: Quality of surgery is essential for survival in gastric adenocarcinoma, but studies examining surgeons' proficiency gain of gastrectomies a......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 188 ()
Background: Germline pathogenic variants (PVs) in BRCA1/2 genes are asso-ciated with breast cancer (BC) risk in both women and men. Multigene panel te......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 189 ()
Background: Early metastatic relapse of triple-negative breast cancer (mTNBC) after anthracyclins and/or taxanes based (A/T) primary treatment represe......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 189 ()
Background: The clinical value of an expert pathological review in patients with an atypical melanocytic lesion diagnosis remains unclear. Herein, we ......
期刊: EUROPEAN JOURNAL OF CANCER, 2023; 190 ()
Background: The PanaMa trial demonstrated significant benefit in progression-free survival with the addition of panitumumab (Pmab) to fluorouracil and......